证券代码：300405 证券简称：科隆股份 公告编号：2024-030 辽宁科隆精细化工股份有限公司 4、会议召开时间： （1）现场会议召开时间：2024 年 5 月 16 日（星期四）下午 13:30。 （2）网络投票时间：2024 年 5 月 16 日。其中，通过深圳证券交易所交易系统进行网络 投票的时间为 2024 年 5 月 16 日 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证券交易 所互联网投票系统投票时间为 2024 年 5 月 16 日上午 9:15 至下午 15:00 的任意时间。 5、会议召开方式：本次股东大会采取现场投票与网络投票相结合的方式召开。 2、股东大会召集人：公司董事会。 3、会议召开的合法、合规性：经公司第五届董事会第十五次会议审议通过，决定召开 2023 年年度股东大会。公司董事会认为召集本次股东大会会议符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》相关规定。 公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈 述或重大遗漏。 根据辽宁科隆精细化工股份有限公司（以下简称"公司"）第五届董事会第十五 ...

辽宁科隆精细化工股份有限公司 独立董事 2023 年度述职报告 辽宁科隆精细化工股份有限公司 独立董事 2023 年度述职报告 作为辽宁科隆精细化工股份有限公司的独立董事，本人在2023年勤勉履行 职责，充分发挥独立董事的作用，严格按照《公司法》、《证券法》、《关于 在上市公司建立独立董事制度的指导意见》、《深圳证券交易所创业板上市公 司规范运作指引》、公司《独立董事工作制度》及《公司章程》等规定和要求， 积极出席相关会议，认真审议董事会各项议案，对公司相关事项发表独立意见， 维护了全体股东尤其是中小股东的合法权益。现将2023年度本人履行的工作情 况向各位股东汇报如下： 一、2023 年出席董事会及股东大会的情况 报告期内，本人担任独立董事期间，公司共召开董事会六次，其中现场会 议一次，现场结合通讯表决五次，本人均全部参加。本人认真审议了董事会提 出的各项议案，凡须董事会决策的事项，公司都提前通知本人并提供了足够的 资料，定期通报公司的运营情况，让本人与其他董事享有同等的知情权。本人 对各次董事会会议相关议案均投了赞成票。 | 姓名 | 应参加董事 | 亲自出席 | 委托出席 | 缺席 | 是否连续两次未亲 ...

Financial Performance - The company's operating revenue for 2023 was ¥558,195,980.29, a decrease of 28.46% compared to ¥780,248,265.23 in 2022[21]. - The net profit attributable to shareholders was -¥100,230,449.54, showing an improvement of 15.60% from -¥118,753,516.11 in the previous year[21]. - The cash flow from operating activities turned positive with a net amount of ¥10,480,417.49, a significant increase of 110.71% from -¥97,825,101.75 in 2022[21]. - The total assets at the end of 2023 were ¥1,266,978,860.14, down 14.23% from ¥1,477,207,507.72 at the end of 2022[21]. - The company's basic earnings per share improved to -¥0.3480, a 15.25% increase from -¥0.4106 in 2022[21]. - The net profit after deducting non-recurring gains and losses was -¥114,673,045.12, a 20.16% improvement from -¥143,624,255.13 in 2022[21]. - The total operating revenue for 2023 was 558,195,980.29 yuan, a decrease of 28.46% compared to 780,248,265.23 yuan in 2022[71]. - The concrete admixture industry accounted for 69.63% of total revenue in 2023, down from 70.15% in 2022, with revenue of 388,684,551.98 yuan, a decline of 28.98%[71]. - The company’s product sales in the other industry segment decreased by 33.73%, from 195,729,799.34 yuan in 2022 to 129,702,827.84 yuan in 2023[72]. Strategic Focus and Development - The company has outlined its development strategy and operational plans, which are subject to market risks and uncertainties[3]. - The report indicates ongoing research and development efforts in new products and technologies, particularly in the field of chemical additives[15]. - The company is focusing on new product development, including high-performance concrete early strength agents and solid alkali-free liquid accelerators, to enhance future sales performance[68]. - The company is actively pursuing research and development of new technologies and products to maintain competitive advantage in the chemical industry[55]. - The company is focusing on expanding its product offerings in environmentally friendly concrete materials, aligning with trends in energy conservation and circular economy[52]. - The company aims to become a leading supplier of eco-friendly concrete additives and related products, leveraging technological innovation to meet customer needs[103]. - The company plans to focus on both internal resource optimization and external business development through strategic investments and acquisitions to enhance profitability[102]. Market and Industry Trends - The company operates in the concrete admixture industry, focusing on the development of new types of concrete additives that meet various performance requirements, driven by national infrastructure investment policies[31]. - The existing product, polycarboxylate superplasticizer, is in a mature phase with a slowing growth rate, but there remains potential for growth in the real estate and infrastructure sectors due to policy support[32]. - The company is positioned to leverage opportunities in the rapidly developing market for energy-efficient and environmentally friendly concrete materials[32]. - The market demand for superplasticizers is expected to grow due to government initiatives in infrastructure construction and urbanization[51]. - The company anticipates that the construction industry will gradually recover, driven by significant infrastructure expansion and the increasing demand for new concrete materials[101]. Governance and Compliance - The annual report emphasizes the commitment of the board and management to ensure the accuracy and completeness of financial reports[3]. - The company is committed to maintaining accurate financial reporting and compliance with regulatory standards[91]. - The company has established effective governance mechanisms to manage its subsidiaries and ensure operational efficiency[111]. - The company has established a risk control management system involving the audit committee and internal audit department to enhance internal control and risk management capabilities[155]. - The company has adhered to all relevant environmental protection laws and standards, confirming compliance with regulatory requirements[161]. Environmental Responsibility - The company emphasizes the environmental benefits of its products, which do not release harmful substances and represent advanced technology in concrete additives[40]. - The company has established pollution prevention facilities, including wastewater treatment systems and exhaust gas absorption devices, which are regularly maintained and operate normally[168]. - The company has achieved certifications for quality management, occupational health and safety management, and environmental management systems[171]. - The company has committed to actively promote the liquidation of its subsidiaries that have ceased operations and aims to complete the liquidation procedures within 6 months[188]. Research and Development - Investment in R&D increased by 30%, focusing on the development of innovative chemical products to enhance market competitiveness[187]. - The company plans to increase R&D investment to strengthen technological innovation and improve product structure, aligning R&D efforts with market demands[107]. - The company is committed to ongoing research and development in new products and technologies to drive future growth[129]. Shareholder Engagement - The company held 1 annual general meeting and 2 extraordinary general meetings during the reporting period, complying with all relevant regulations[116]. - The company approved the 2022 annual financial report and profit distribution plan during the annual shareholders meeting[123]. - The company plans to implement a stock incentive plan in 2023, which was approved by the board and supervisory committee[149]. - The company has proposed a 2023 equity incentive plan for shareholders' approval[123]. Risk Management - The company continues to face uncertainty regarding its ability to continue as a going concern, as indicated in the audit report[21]. - The company faces risks related to raw material supply and price fluctuations, particularly with ethylene oxide, which is sensitive to market changes[109]. - The company has established a clear process for disclosing related transactions to avoid conflicts of interest[185]. Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% driven by new product launches and market expansion strategies[187]. - Future guidance includes maintaining a strong focus on sustainability initiatives, aiming for a 50% reduction in carbon emissions by 2025[187]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[187].

2023 年度关联交易及 2024 年度关联交易计划的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 一、2023 年度关联交易情况 1、2023 年度内，公司与关联方未发生产品或服务采购、销售、租赁等与 生产经营直接相关的关联交易，未发生资金往来、拆借等关联交易；2023 年度 内公司与关联方仅发生如下关联交易： （一）关联担保 证券代码：300405 证券简称：科隆股份 公告编号：2024-023 辽宁科隆精细化工股份有限公司 公司在获得上述额度的融资时，除以公司自有资产为以上融资提供抵押、 质押等担保措施外，公司控股股东及实际控制人姜艳女士拟将根据每笔债务的 实际情况及债权人的具体要求为上述融资提供个人连带责任担保。本次关联担 保额度的有效期为自 2023 年度股东大会通过之日起至 2024 年度股东大会召开 日止，每笔担保金额及担保期间以实际签署的担保协议为准。 | 担保方 | 被担保方 担保金额 | 担保起始日 担保到期日 | 担保是否已 | | --- | --- | --- | --- | | | | | 经履行完毕 | | 姜艳 | 辽宁科 ...

大信审字[2024]第 11-00098 号 辽宁科隆精细化工股份有限 公司 审计报告 大信会计师事务所(特殊普通合伙) WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 您可使用手机"打一打"或进入"控制婴干燥料签装|张春平台（http://zec.mri.gov.cn） 【 WUYIGE Certified Public Accountants LLF 电话 Telephone: +86 10 /82330558 1 日 15/F Xuevuan International No 1Zhichun Road Haidian Dist Beljing China 100083 Tower 传真Fax: +86 (10) 82327668 Internet: www.daxincpa.com.cn 审计报告 大信审字[2024]第11-00098 号 辽宁科隆精细化工股份有限公司全体股东; 一、审计意见 (一) 应收账款减值 l. 事项描述 如财务报表附注五(三)应收账款所述,截至2023年12月31日,贵公司应收账款账面余额 50. 496.83万元,公司管理层已计提杯账准备 ...

Financial Performance - The company's revenue for Q1 2024 was ¥138,973,187.50, a decrease of 6.44% compared to ¥148,531,576.33 in the same period last year[4] - Total operating revenue for Q1 2024 was 139,112,944.92, a decrease of 6.8% compared to 148,622,174.15 in the previous period[23] - The net loss attributable to shareholders was ¥9,027,818.26, representing a 51.23% increase in loss from ¥5,969,724.87 year-over-year[4] - Net loss for Q1 2024 was -9,108,412.55, compared to a net loss of -6,027,318.36 in the same period last year, reflecting a deterioration in performance[24] - The total comprehensive income for the first quarter was -9,108,412.55 CNY, compared to -6,027,318.36 CNY in the previous year, indicating a decline of approximately 51.5%[25] - Basic and diluted earnings per share were both -¥0.0321, a decrease of 55.83% from -¥0.0206 in the same quarter last year[4] Cash Flow - The net cash flow from operating activities was -¥35,180,642.88, a significant decline of 230.01% compared to -¥10,660,528.61 in the previous year[4] - Cash inflow from operating activities totaled 156,649,888.71 CNY, down 27.5% from 216,009,827.29 CNY in the previous period[27] - Cash outflow from operating activities was 191,830,531.59 CNY, a decrease of 15.4% compared to 226,670,355.90 CNY last year[27] - The net cash flow from investing activities was -1,655,610.07 CNY, improving from -4,245,629.29 CNY in the previous year[28] - Cash inflow from financing activities was 375,751,346.61 CNY, a substantial increase from 169,659,247.30 CNY year-over-year[28] - The net cash flow from financing activities was -13,862,203.85 CNY, contrasting with a positive flow of 18,862,075.00 CNY in the previous year[28] - The ending balance of cash and cash equivalents was 76,838,652.12 CNY, down from 113,992,913.45 CNY in the previous year[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,174,248,799.60, down 7.32% from ¥1,266,978,860.14 at the end of the previous year[4] - Total current assets decreased from 793,608,665.95 to 706,933,096.29, a decline of 10.9%[21] - Total liabilities decreased from 746,802,605.52 to 672,952,034.32, a reduction of 9.8%[22] - The company’s equity attributable to shareholders decreased from 507,982,095.03 to 489,183,199.98, a decrease of 3.7%[22] Research and Development - The company's R&D expenses increased by 45.16% to ¥2,237,274.73 from ¥1,541,214.62 in the same period last year[8] - The company reported a research and development expense of 2,237,274.73, which increased from 1,541,214.62 in the previous period, indicating a focus on innovation[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,077[10] - The company plans to repurchase shares with a total fund of no less than RMB 10 million and no more than RMB 20 million, with a maximum repurchase price of RMB 6.50 per share[15] - As of February 26, 2024, the company has repurchased 1,931,200 shares, accounting for 0.68% of the total share capital, with a total transaction amount of RMB 9,999,725.20[17] - By February 29, 2024, the company repurchased a total of 1,932,800 shares, with a total transaction amount of RMB 10,007,933.20[18] - The maximum transaction price during the repurchase was RMB 5.28 per share, and the minimum was RMB 5.04 per share[18] - The company’s major shareholder, Jiang Yan, holds 64,163,140 shares, which are subject to lock-up restrictions[14] - The company has announced a plan for senior management to increase their holdings, with a total planned investment of no less than RMB 100,000 and no more than RMB 200,000[15] - The company is committed to enhancing investor confidence and maintaining the value of the company through share repurchase[16] - The repurchase plan is set to last for no more than three months from the board's approval date[17] - The company’s stock repurchase is aimed at protecting shareholder interests and recognizing the company's value[16] Other Information - The company has not disclosed any changes in the status of major shareholders participating in margin trading[11] - The company has not undergone an audit for the first quarter report[29]

辽宁科隆精细化工股份有限公司 关于 2023 年度利润分配预案的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 证券代码：300405 证券简称：科隆股份 公告编号：2024-020 二、公司未分配利润的用途和计划 公司留存未分配利润主要用于市场开拓及投入、技术研发、及相关产业资源 的整合、对外投资、收购资产、购买设备等重大投资及现金支出，逐步扩大生产 经营规模，优化财务结构，促进公司的快速发展，有计划有步骤地实现公司未来 的发展规划目标，最终实现股东利益最大化。 三、 审议程序及相关意见说明 1、独立董事专门会议意见 重要内容提示： 1、公司第五届董事会第十五次会议审议通过了《2023 年度利润分配的预 案》：2023 年度不派发现金红利，不送红股，不以公积金转增股本。 2、该议案尚需提交公司 2023 年度股东大会审议。 辽宁科隆精细化工股份有限公司（以下简称"公司"）第五届董事会第十五 次会议审议通过了《2023 年度利润分配的预案》，为了充分保护广大投资者的 利益，现将有关情况公告如下： 一、2023 年度不进行利润分配的原因 1、根据《公司章程》 ...

辽宁科隆精细化工股份有限公司（以下简称"本公司"或"公司"）于 2024 年 4 月 24 日召开第五届董事会第十五次会议。 1、发出会议通知的时间和方式：2024 年 4 月 12 日以书面、邮件方式通知 各位董事； 2、会议召开时间：2024 年 4 月 24 日上午； 证券代码：300405 证券简称：科隆股份 公告编号：2024-018 辽宁科隆精细化工股份有限公司 第五届董事会第十五次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、董事会会议召开情况 表决结果：9 票同意，0 票反对，0 票弃权。 6、会议主持人：董事长姜艳女士； 7、召开情况合法、合规、合章程性说明：会议召开及表决符合《公司法》 及《公司章程》的有关规定，会议合法有效。 二、董事会会议审议情况 本次会议审议并通过如下决议： 2、审议通过《2023 年度董事会工作报告》（议案 2） 1、审议通过《2023 年度总经理工作报告》（议案 1） 3、会议召开地点：公司二楼会议室； 该项议案无需提交股东大会审议。 4、会议召开方式：现场会议方式召开； 5、会议出席情况：本次会 ...

辽宁科隆精细化工股份有限 公司 内部控制鉴证报告 大信专审字[2024]第 11-00053 号 大信会计师事务所（特殊普通合伙） WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 大信会计师事务所 北京市海淀区知春路 1 号 学院国际大厦 22 层 2206 邮编 100083 辽宁科隆精细化工股份有限公司全体股东： 我们接受委托，对辽宁科隆精细化工股份有限公司(以下简称"贵公司") 2023 年 12 月 31 日与财务报告相关的内部控制有效性的认定进行了鉴证。 一、管理层对内部控制的责任 按照国家有关法律法规的规定，设计、实施和维护有效的内部控制，并评价其有效性 是贵公司管理层的责任。 二、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对内部控制有效性发表鉴证意见。我们按照 《中国注册会计师其他鉴证业务准则第3101号—历史财务信息审计或审阅以外的鉴证业 务》的规定执行了鉴证工作。该准则要求我们计划和实施鉴证工作，以对鉴证对象信息是 否不存在重大错报获取合理保证。在鉴证过程中，我们实施了包括了解、测试和评价内部 控制设计的合理性和执行的有效性，以及我们认为必要的其他 ...

辽宁科隆精细化工股份有限公司 独立董事关于 2023 年度独立性的自查报告 本人高倚云，于 2022 年 07 月起任职辽宁科隆精细化工股份有限公司（以下 简称"上市公司"）独立董事，在 2023 年度任职时间为 2023 年 1 月 1 日-2023 年 12 月 31 日。 本人严格遵守《公司法》《上市公司治理准则》和《上市公司独立董事管理 办法》等法律法规以及《公司章程》对独立董事的任职要求，持续保持独立性。 本人 2023 年度独立性自查情况如下： | 序号 | 事项 | 自查结果 | | --- | --- | --- | | 1 | 在上市公司或者其附属企业任职的人员及其配偶、父母、子女、主 | 是否√ | | | 要社会关系； | | | 2 | 直接或者间接持有上市公司已发行股份百分之一以上或者是上市公 | 是否√ | | | 司前十名股东中的自然人股东及其配偶、父母、子女； | | | 3 | 在直接或者间接持有上市公司已发行股份百分之五以上的股东或者 | 是否√ | | | 在上市公司前五名股东任职的人员及其配偶、父母、子女； | | | 4 | 在上市公司控股股东、实际控制人的附属 ...